Cargando…
Human iPSC-Based Models for the Development of Therapeutics Targeting Neurodegenerative Lysosomal Storage Diseases
Lysosomal storage diseases (LSDs) are a group of rare genetic conditions. The absence or deficiency of lysosomal proteins leads to excessive storage of undigested materials and drives secondary pathological mechanisms including autophagy, calcium homeostasis, ER stress, and mitochondrial abnormaliti...
Autores principales: | Luciani, Marco, Gritti, Angela, Meneghini, Vasco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530250/ https://www.ncbi.nlm.nih.gov/pubmed/33062642 http://dx.doi.org/10.3389/fmolb.2020.00224 |
Ejemplares similares
-
Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases
por: Favret, Jacob M., et al.
Publicado: (2020) -
Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy
por: Frati, Giacomo, et al.
Publicado: (2018) -
CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges
por: Edelmann, Mariola J., et al.
Publicado: (2020) -
Modeling Lysosomal Storage Diseases in the Zebrafish
por: Zhang, T., et al.
Publicado: (2020) -
iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)